EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility

Ryan J Jalleh iD, Chinmay S Marathe, Christopher K Rayner iD, Karen L Jones iD, Mahesh M Umapathysivam, Tongzhi Wu, Daniel R Quast, Mark P Plummer, Michael A Nauck iD, Michael Horowitz iD

Endocrinology · 26.11.2024 · 166 (1)

DOI: 10.1210/endocr/bqae155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 21.11.2024. Verfasst von Ryan J Jalleh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Gastrointestinal Motility, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide-1 (GLP-1) receptor agonists and the dual GLP-1- and glucose-dependent insulinotropic polypeptide receptor co-agonist tirzepatide (referred to here collectively as “GLP-1-based therapy”) are incretin-based therapies being used increasingly in the management of both type 2 diabetes and obesity. They are now recognized to have beneficial effects beyond improved glycemic control and weight loss, including cardiovascular and renal protection. GLP-1-based therapy also slows gastric emptying, which has benefits (lowering postprandial glucose), but also potential risks (eg, hypoglycemia in individuals on insulin or sulphonylurea therapy). Their effects on the gallbladder may also be beneficial, contributing to reducing postprandial triglycerides, but they also potentially increase the risk of biliary disease. In this review, we summarize the effects of GLP-1 and incretin-based therapeutics on gastric, biliary and small intestinal function. An improved understanding of these effects will optimize the use of these drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1Gastrointestinal MotilityDiabetes Mellitus, Type 2HumansAnimalsGastric EmptyingIncretinsBiliary TractHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

biliarygastric emptyingglucagon-like peptide-1hypoglycemiaphysiologysmall intestinal motility

Substanzen

Glucagon-Like Peptide 1IncretinsHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsGLP1R protein, humanGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
  • Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia.
  • Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
  • Southern Adelaide Diabetes and Endocrine Service, Flinders Medical Centre, Bedford Park, SA 5042, Australia.
  • Diabetes, Endocrinology, Metabolism Section, Medical Department I, Katholisches Klinikum Bochum gGmbH, Sankt Josef-Hospital, Ruhr-University, D-44791 Bochum, Germany.
  • Intensive Care Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.

ORCID-Profile: Ryan J Jalleh, Christopher K Rayner, Karen L Jones, Michael A Nauck, Michael Horowitz

Zitieren

APA

Jalleh, R. J., Marathe, C. S., Rayner, C. K., Jones, K. L., Umapathysivam, M. M., Wu, T., Quast, D. R., Plummer, M. P., Nauck, M. A., & Horowitz, M. (2024). Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility. Endocrinology, 166(1). https://doi.org/10.1210/endocr/bqae155

Vancouver

Jalleh RJ, Marathe CS, Rayner CK, Jones KL, Umapathysivam MM, Wu T, et al. Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility. Endocrinology. 2024;166(1). doi:10.1210/endocr/bqae155

BibTeX
@article{Jalleh2024,
  author = {Jalleh, Ryan J and Marathe, Chinmay S and Rayner, Christopher K and Jones, Karen L and Umapathysivam, Mahesh M and Wu, Tongzhi and Quast, Daniel R and Plummer, Mark P and Nauck, Michael A and Horowitz, Michael},
  title = {Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility},
  journal = {Endocrinology},
  year = {2024},
  volume = {166},
  number = {1},
  doi = {10.1210/endocr/bqae155}
}
Kostenlos starten →